Syndax Pharmaceuticals Inc (SNDX)
22.38
-0.80
(-3.45%)
USD |
NASDAQ |
May 08, 16:00
22.39
+0.01
(+0.04%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Operations (TTM): -160.60M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -160.60M |
September 30, 2023 | -142.15M |
June 30, 2023 | -126.04M |
March 31, 2023 | -130.97M |
December 31, 2022 | -133.68M |
September 30, 2022 | -10.07M |
June 30, 2022 | -6.472M |
March 31, 2022 | 9.789M |
December 31, 2021 | 29.13M |
September 30, 2021 | -87.21M |
June 30, 2021 | -80.56M |
March 31, 2021 | -77.92M |
December 31, 2020 | -71.26M |
September 30, 2020 | -68.36M |
June 30, 2020 | -58.59M |
March 31, 2020 | -49.71M |
December 31, 2019 | -50.61M |
September 30, 2019 | -52.93M |
June 30, 2019 | -62.87M |
March 31, 2019 | -65.49M |
December 31, 2018 | -68.53M |
Date | Value |
---|---|
September 30, 2018 | -66.21M |
June 30, 2018 | -57.92M |
March 31, 2018 | -54.57M |
December 31, 2017 | -47.37M |
September 30, 2017 | -45.06M |
June 30, 2017 | -46.33M |
March 31, 2017 | -41.42M |
December 31, 2016 | -35.16M |
September 30, 2016 | -29.04M |
June 30, 2016 | -22.77M |
March 31, 2016 | -19.88M |
December 31, 2015 | -2.428M |
September 30, 2015 | -1.608M |
June 30, 2015 | 0.972M |
March 31, 2015 | 1.164M |
December 31, 2014 | -14.39M |
September 30, 2014 | -13.67M |
June 30, 2014 | -13.20M |
March 31, 2014 | -10.32M |
December 31, 2013 | -7.295M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-160.60M
Minimum
Dec 2023
29.13M
Maximum
Dec 2021
-70.06M
Average
-68.36M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
SpringWorks Therapeutics Inc | -239.91M |
Alnylam Pharmaceuticals Inc | 189.12M |
Geron Corp | -183.63M |
Ionis Pharmaceuticals Inc | -323.46M |
Madrigal Pharmaceuticals Inc | -324.23M |